Biotech: Pressemitteilungen - Kategorie - Seite 253

Biotech

Category / Pharmaceuticals & Biotech / Biotech


Functional Technologies Announces Third Quarter 2011 Financial Results

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 07/29/11 -- Functional Technologies Corp. (TSX VENTURE: FEB) (the "Company") today reported operational and financial results for the third q ...

OctoPlus Announces 2011 First Half-Year Results

LEIDEN, NETHERLANDS: LEIDEN, NETHERLANDS -- (Marketwire) -- 07/29/11 -- OctoPlus N.V. ("OctoPlus" or the "Company") (Euronext: OCTO), the specialty pharmaceutical company, announces today its results ...

The Medicines Company Appoints Glenn P. Sblendorio to Board of Directors

PARSIPPANY, NJ: PARSIPPANY, NJ -- (Marketwire) -- 07/28/11 -- The Medicines Company (NASDAQ: MDCO) today announced the appointment of Glenn Sblendorio to the Company's Board of Directors. Mr. Sblendorio has be ...

ISTA Pharmaceuticals Reports Second Quarter 2011 Financial Results

IRVINE, CA: Revenues Increased 6% From Prior Year Quarter to $37.1 Million BEPREVE 2011 Year-to-Date Revenues Grew 145% Compared to First Half 2010 ISTA Reaffirms 2011 Guidance for Net Revenues and Adjusted Cash ...

ISTA Pharmaceuticals Reports Results From the First of Two Trials in the REMURA(TM) Phase 3 Clinical Program for Dry Eye Disease

IRVINE, CA: IRVINE, CA -- (Marketwire) -- 07/28/11 -- ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA), today announced top-line results from the first of its two Phase 3 studies to evaluate the short-term safety and ...

Cytokinetics, Incorporated Reports Second Quarter 2011 Financial Results

SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 07/28/11 -- Cytokinetics, Incorporated (NASDAQ: CYTK) reported total research and development revenues of $1.1 million for the second quarter of 2011. The ...

AMI Research Updates Analyst Coverage on NeoGenomics; Maintains Outlook

NEW YORK, NY: NEW YORK, NY -- (Marketwire) -- 07/28/11 -- AMI Research, () a leading provider of equity research reports and a division of IR Firm, Hawk Associates Inc., announced today that it has published upda ...

Horizon Pharma Announces Pricing of Its Initial Public Offering

NORTHBROOK, IL: NORTHBROOK, IL -- (Marketwire) -- 07/28/11 -- Horizon Pharma, Inc. (NASDAQ: HZNP) today announced the pricing of its initial public offering of 5,500,000 shares of common stock at a price to the publ ...

Critical Outcome Technologies Inc. Initiates Synthesis of Another Key Asset: Acute Myelogenous Leukemia Drug Candidates

LONDON, ONTARIO: LONDON, ONTARIO -- (Marketwire) -- 07/28/11 -- Critical Outcome Technologies Inc. (COTI) (TSX VENTURE: COT) announced today that it has initiated synthesis on compounds from COTI's acute myelog ...

Bio-Solutions Corp Signs First American Distribution Agreement to Enter $45 Billion USA Poultry Market

MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwire) -- 07/27/11 -- Bio-Solutions Corp (OTCBB: BISU)(PINK SHEETS: BISU) is proud to announce that it has signed a distribution agreement with it's first American dis ...

Two Patent Grants Add to Stem Cell Therapeutics Corp. Patent Portfolio and Expand Geographic Coverage of Key Stem Cell Technologies

CALGARY, ALBERTA: CALGARY, ALBERTA -- (Marketwire) -- 07/27/11 -- Stem Cell Therapeutics Corp. (TSX VENTURE: SSS) ("SCT" or the "Company") is pleased to announce that it has received notification ...

Effect of Aug 2. Deadline, Market Dynamics to Consider - Research Report on athenahealth, Inc. and SXC Health Solutions Corp.

MACAU: MACAU -- (Marketwire) -- 07/27/11 -- Today, announced its research report highlighting athenahealth, Inc. (NASDAQ: ATHN) and SXC Health Solutions Corp. (NASDAQ: SXCI). Full content and research is ...

Miraculins Announces Grant of Options

WINNIPEG, MANITOBA: WINNIPEG, MANITOBA -- (Marketwire) -- 07/26/11 -- Miraculins Inc. (TSX VENTURE: MOM), a medical diagnostic company focused on developing and commercializing diagnostic tests and risk assessment tool ...

Critical Outcome Technologies Inc. Receives Another Key Asset: A Canadian Patent in Support of Its Acute Myelogenous Leukemia Program

LONDON, ONTARIO: LONDON, ONTARIO -- (Marketwire) -- 07/26/11 -- Critical Outcome Technologies Inc. (COTI) (TSX VENTURE: COT) announced today that a patent for its protein tyrosine kinase inhibitors supporting the Co ...

Poniard Pharmaceuticals Announces Filing of Form S-4 Registration Statement Related to Proposed Merger With ALLOZYNE

SAN FRANCISCO, CA: Company to Seek Shareholder Approval of Merger, Reverse Stock Split; Pending Appeal, Company Received Notice of Delisting From The Nasdaq Capital Market ...

Celsion Announces Closing of $18.4 Million in Financing

COLUMBIA, MD: Triggers Conversion of All Preferred Stock ...

FFF Enterprises Announces Early Shipment of Seasonal Flu Vaccine

TEMECULA, CA: The Nation's Largest and Most Trusted Distributor of Flu Vaccine Has Begun Shipment of Influenza Vaccine Through Its MyFluVaccine Program, Paving the Way for Early Influenza Vaccinations Nationwi ...

Celsion Announces Relocation of Corporate Headquarters to Lawrenceville, New Jersey

COLUMBIA, MD: COLUMBIA, MD -- (Marketwire) -- 07/25/11 -- Celsion Corporation (NASDAQ: CLSN), a leading oncology drug development company, today announced that it expects to relocate its operations and corporate ...

Agennix Schedules Conference Call on August 4 to Discuss Second Quarter of 2011 Financial Results

PLANEGG, GERMANY and MUNICH, GERMANY and PRINCETON, NJ and HOUSTON, TX: PLANEGG, GERMANY and MUNICH, GERMANY and PRINCETON, NJ and HOUSTON, TX -- (Marketwire) -- 07/25/11 -- Agennix AG (FRANKFURT: AGX) (XETRA: AGX) announced today that the Company will hold a conferenc ...


Seite 253 von 255:  « ..  251  252 253 254  255 





 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z